UROCLINIC: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
UROCLINIC
Largest movements
- Receivables within one year +€15,869
up €15,869 (+461%), from €3,444 to €19,313
- Cash +€7,099
up €7,099 (+9.1%), from €78,294 to €85,393
mainly Other debts (+€78,897) and Net result for the year (+€7,822)
- Deferred charges and accrued income -€6,644
down €6,644 (-17.8%), from €37,395 to €30,751
- Tangible fixed assets -€3,675
down €3,675 (-11.6%), from €31,605 to €27,931
of which Plant, machinery and equipment: -€4,099
- Other debts +€78,897
up €78,897 (+487,620%), from €16 to €78,913
- Reserves -€63,758
down €63,758 (-52.6%), from €121,137 to €57,379
of which Non-distributable reserves: -€76,000
- Profit (loss) carried forward -€4,420
no longer reported in 2025 (was €4,420)
- Tax, wage and social debts +€1,930
up €1,930 (+15.1%), from €12,765 to €14,695
of which Taxes: +€1,454
- Gross operating margin +€3,764
up €3,764 (+5.8%), from €65,237 to €69,002
- Staff costs +€3,480
up €3,480 (+7.2%), from €48,663 to €52,142
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €150,738 | €163,387 | +€12,649 | +8.4% |
| Fixed assets | 21/28 | €31,605 | €27,931 | -€3,675 | -11.6% |
| Tangible fixed assets | 22/27 | €31,605 | €27,931 | -€3,675 | -11.6% |
| Plant, machinery and equipment | 23 | €30,569 | €26,470 | -€4,099 | -13.4% |
| Furniture and vehicles | 24 | €1,036 | €1,460 | +€424 | +40.9% |
| Current assets | 29/58 | €119,133 | €135,457 | +€16,324 | +13.7% |
| Amounts receivable within one year | 40/41 | €3,444 | €19,313 | +€15,869 | +461% |
| Trade receivables | 40 | €3,444 | €19,313 | +€15,869 | +461% |
| Cash at bank and in hand | 54/58 | €78,294 | €85,393 | +€7,099 | +9.1% |
| Deferred charges and accrued income | 490/1 | €37,395 | €30,751 | -€6,644 | -17.8% |
| Total equity and liabilities | 10/49 | €150,738 | €163,387 | +€12,649 | +8.4% |
| Equity | 10/15 | €137,957 | €69,779 | -€68,178 | -49.4% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €121,137 | €57,379 | -€63,758 | -52.6% |
| Non-distributable reserves | 130/1 | €121,137 | €45,137 | -€76,000 | -62.7% |
| Reserves not available under the articles | 1311 | €121,137 | €45,137 | -€76,000 | -62.7% |
| Distributable reserves | 133 | - | €12,242 | +€12,242 | |
| Profit (loss) carried forward | 14 | €4,420 | - | -€4,420 | |
| Amounts payable | 17/49 | €12,781 | €93,608 | +€80,827 | +632% |
| Amounts payable within one year | 42/48 | €12,781 | €93,608 | +€80,827 | +632% |
| Taxes, remuneration and social security | 45 | €12,765 | €14,695 | +€1,930 | +15.1% |
| Taxes | 450/3 | €4,065 | €5,518 | +€1,454 | +35.8% |
| Remuneration and social security | 454/9 | €8,700 | €9,177 | +€477 | +5.5% |
| Other amounts payable | 47/48 | €16 | €78,913 | +€78,897 | +487,620% |
| Remuneration, social security and pensions | 62 | €48,663 | €52,142 | +€3,480 | +7.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,593 | €4,774 | +€181 | +3.9% |
| Other operating charges | 640/8 | €384 | €387 | +€3 | +0.8% |
| Gross operating margin | 9900 | €65,237 | €69,002 | +€3,764 | +5.8% |
| Operating profit (loss) | 9901 | €11,598 | €11,698 | +€101 | +0.9% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €153 | €158 | +€5 | +3.2% |
| Recurring financial charges | 65 | €153 | €158 | +€5 | +3.2% |
| Profit (loss) for the period before taxes | 9903 | €11,444 | €11,540 | +€96 | +0.8% |
| Income taxes | 67/77 | €4,065 | €3,718 | -€346 | -8.5% |
| Profit (loss) for the period | 9904 | €7,380 | €7,822 | +€442 | +6.0% |
| Profit (loss) for the period to be appropriated | 9905 | €7,380 | €7,822 | +€442 | +6.0% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.